APLS insider transaction filings
Apellis Pharmaceuticals, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-14. Screen APLS transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-14 | 4 | Dunlop A. Sinclair — Director | Code (U): 161,567 · Disposition to issuer (D): 3,062 · Disposition to issuer (D): 5,744 · Disposition to issuer (D): 7,961 · Disposition to issuer (D): 3,544 · Disposition to issuer (D): 14,684 (derivative) · +6 more | EDGAR |
| 2026-05-14 | 4 | Chopas James George — VP/Chief Accounting Officer | Code (U): 65,955 · Grant/award (A): 5,625 · Disposition to issuer (D): 5,625 · Grant/award (A): 8,394 · Disposition to issuer (D): 8,394 · Grant/award (A): 16,150 · +13 more | EDGAR |
| 2026-05-14 | 4 | MELTZER LESLIE — Chief Research and Development | Code (U): 107,024 · Grant/award (A): 22,610 · Disposition to issuer (D): 22,610 · Grant/award (A): 45,220 · Disposition to issuer (D): 45,220 · Disposition to issuer (D): 61,804 · +2 more | EDGAR |
| 2026-05-14 | 4 | FONTEYNE PAUL R. — Director | Code (U): 30,666 · Disposition to issuer (D): 3,062 · Disposition to issuer (D): 5,744 · Disposition to issuer (D): 7,961 · Disposition to issuer (D): 3,544 · Disposition to issuer (D): 3,877 · +7 more | EDGAR |
| 2026-05-14 | 4 | Sullivan Timothy Eugene — Chief Financial Officer | Code (U): 140,945 · Code (U): 71,492 · Grant/award (A): 41,250 · Disposition to issuer (D): 41,250 · Grant/award (A): 30,620 · Disposition to issuer (D): 30,620 · +17 more | EDGAR |
| 2026-05-14 | 4 | Machiels Alec — Director | Code (U): 384,989 · Code (U): 250,000 · Code (U): 11,950 · Code (U): 150,000 · Disposition to issuer (D): 3,062 · Disposition to issuer (D): 5,744 · +11 more | EDGAR |
| 2026-05-14 | 4 | Deschatelets Pascal — Chief Scientific Officer | Code (U): 1,177,222 · Grant/award (A): 41,250 · Disposition to issuer (D): 41,250 · Grant/award (A): 10,030 · Disposition to issuer (D): 10,030 · Grant/award (A): 12,920 · +16 more | EDGAR |
| 2026-05-14 | 4 | Chan Gerald — Director | Code (U): 25,666 · Disposition to issuer (D): 3,062 · Disposition to issuer (D): 5,744 · Disposition to issuer (D): 7,961 · Disposition to issuer (D): 3,877 · Disposition to issuer (D): 3,544 · +9 more | EDGAR |
| 2026-05-14 | 4 | Nicholson Nur — Chief Technical Officer | Code (U): 116,338 · Grant/award (A): 22,610 · Disposition to issuer (D): 22,610 · Grant/award (A): 45,220 · Disposition to issuer (D): 45,220 · Grant/award (A): 24,284 · +13 more | EDGAR |
| 2026-05-14 | 4 | Walbert Keli — Director | Code (U): 17,051 · Disposition to issuer (D): 8,332 · Disposition to issuer (D): 664 · Disposition to issuer (D): 7,297 · Disposition to issuer (D): 14,684 (derivative) · Disposition to issuer (D): 15,388 (derivative) | EDGAR |
| 2026-05-14 | 4 | DeLong Mark Jeffrey — Chief Business & Strat Officer | Code (U): 114,591 · Grant/award (A): 41,250 · Disposition to issuer (D): 41,250 · Grant/award (A): 19,006 · Disposition to issuer (D): 19,006 · Grant/award (A): 36,606 · +15 more | EDGAR |
| 2026-05-14 | 4 | O'Brien Stephanie Monaghan — Director | Code (U): 25,666 · Code (U): 5,750 · Disposition to issuer (D): 3,062 · Disposition to issuer (D): 5,744 · Disposition to issuer (D): 7,961 · Disposition to issuer (D): 3,877 · +10 more | EDGAR |
| 2026-05-14 | 4 | Boucher Kelley — Chief People Officer | Code (U): 127,804 · Grant/award (A): 15,073 · Disposition to issuer (D): 15,073 · Grant/award (A): 30,146 · Disposition to issuer (D): 30,146 · Disposition to issuer (D): 22,087 · +6 more | EDGAR |
| 2026-05-14 | 4 | Watson David O. — General Counsel | Code (U): 144,517 · Code (U): 10,000 · Code (U): 50,136 · Grant/award (A): 41,250 · Disposition to issuer (D): 41,250 · Grant/award (A): 28,508 · +17 more | EDGAR |
| 2026-05-14 | 4 | Francois Cedric — Chief Executive Officer, Director | Code (U): 425,968 · Code (U): 372,815 · Code (U): 472,065 · Code (U): 300,000 · Code (U): 234,411 · Grant/award (A): 143,750 · +20 more | EDGAR |
| 2026-05-14 | 4 | Baumal Caroline — Chief Medical Officer | Code (U): 86,525 · Grant/award (A): 41,250 · Disposition to issuer (D): 41,250 · Grant/award (A): 26,396 · Disposition to issuer (D): 26,396 · Disposition to issuer (D): 8,888 · +5 more | EDGAR |
| 2026-05-14 | 4 | Dolsten Mikael — Director | Code (U): 14,312 · Disposition to issuer (D): 14,312 · Disposition to issuer (D): 24,135 (derivative) | EDGAR |
| 2026-05-14 | 4 | WHEELER CRAIG A — Director | Code (U): 24,444 · Disposition to issuer (D): 15,110 · Disposition to issuer (D): 7,961 · Disposition to issuer (D): 28,195 (derivative) · Disposition to issuer (D): 14,684 (derivative) | EDGAR |
| 2026-05-01 | 4 | Baumal Caroline — Chief Medical Officer | Gift (G): 900 @ $0 | EDGAR |
| 2026-04-20 | 4 | Sullivan Timothy Eugene — Chief Financial Officer | Gift (G): 11,096 @ $0 · Gift (G): 11,096 @ $0 | EDGAR |
| 2026-04-08 | 4 | O'Brien Stephanie Monaghan — Director | Other (J): 5,750 @ $0 | EDGAR |
| 2026-03-13 | 4 | Francois Cedric — Chief Executive Officer, Director | Gift (G): 64,869 @ $0 · Gift (G): 64,869 @ $0 | EDGAR |
| 2026-03-03 | 4 | Dolsten Mikael — Director | Grant/award (A): 14,312 @ $0 · Grant/award (A): 24,135 (derivative) @ $20.96 | EDGAR |
| 2026-02-13 | 4 | DeLong Mark Jeffrey — Chief Business & Strat Officer | Sale (S): 368 @ $22.15 | EDGAR |
| 2026-02-05 | 4 | Francois Cedric — Chief Executive Officer, Director | Option exercise (M): 8,840 @ $3.76 · Option exercise (M): 8,840 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Boucher Kelley — Chief People Officer | Grant/award (A): 30,146 @ $0 | EDGAR |
| 2026-01-30 | 4 | Chopas James George — VP/Chief Accounting Officer | Grant/award (A): 16,150 @ $0 | EDGAR |
| 2026-01-30 | 4 | DeLong Mark Jeffrey — Chief Business & Strat Officer | Grant/award (A): 36,606 @ $0 | EDGAR |
| 2026-01-30 | 4 | Deschatelets Pascal — Chief Scientific Officer | Grant/award (A): 25,840 @ $0 | EDGAR |
| 2026-01-30 | 4 | MELTZER LESLIE — Chief Research and Development | Grant/award (A): 45,220 @ $0 | EDGAR |
| 2026-01-30 | 4 | Nicholson Nur — Chief Technical Officer | Grant/award (A): 45,220 @ $0 | EDGAR |
| 2026-01-30 | 4 | Sullivan Timothy Eugene — Chief Financial Officer | Grant/award (A): 58,140 @ $0 | EDGAR |
| 2026-01-30 | 4 | Watson David O. — General Counsel | Grant/award (A): 55,986 @ $0 | EDGAR |
| 2026-01-30 | 4 | Francois Cedric — Chief Executive Officer, Director | Grant/award (A): 195,952 @ $0 | EDGAR |
| 2026-01-23 | 4 | Baumal Caroline — Chief Medical Officer | Sale (S): 2,797 @ $21.77 | EDGAR |
| 2026-01-23 | 4 | Chopas James George — VP/Chief Accounting Officer | Sale (S): 2,064 @ $21.77 | EDGAR |
| 2026-01-23 | 4 | DeLong Mark Jeffrey — Chief Business & Strat Officer | Sale (S): 3,371 @ $21.77 | EDGAR |
| 2026-01-23 | 4 | Deschatelets Pascal — Chief Scientific Officer | Sale (S): 5,928 @ $21.77 | EDGAR |
| 2026-01-23 | 4 | Francois Cedric — Chief Executive Officer, Director | Sale (S): 27,192 @ $21.77 | EDGAR |
| 2026-01-23 | 4 | Nicholson Nur — Chief Technical Officer | Sale (S): 7,725 @ $21.77 | EDGAR |
| 2026-01-23 | 4 | Sullivan Timothy Eugene — Chief Financial Officer | Sale (S): 10,287 @ $21.77 | EDGAR |
| 2026-01-23 | 4 | Watson David O. — General Counsel | Sale (S): 7,832 @ $21.77 | EDGAR |
| 2026-01-21 | 4 | Baumal Caroline — Chief Medical Officer | Sale (S): 1,882 @ $19.79 | EDGAR |
| 2026-01-21 | 4 | Chopas James George — VP/Chief Accounting Officer | Sale (S): 726 @ $19.79 | EDGAR |
| 2026-01-21 | 4 | DeLong Mark Jeffrey — Chief Business & Strat Officer | Sale (S): 1,334 @ $19.79 | EDGAR |
| 2026-01-21 | 4 | Deschatelets Pascal — Chief Scientific Officer | Sale (S): 909 @ $19.79 | EDGAR |
| 2026-01-21 | 4 | Francois Cedric — Chief Executive Officer, Director | Sale (S): 8,182 @ $19.79 | EDGAR |
| 2026-01-21 | 4 | Nicholson Nur — Chief Technical Officer | Sale (S): 2,203 @ $19.79 | EDGAR |
| 2026-01-21 | 4 | Sullivan Timothy Eugene — Chief Financial Officer | Sale (S): 2,892 @ $19.79 | EDGAR |
| 2026-01-21 | 4 | Watson David O. — General Counsel | Sale (S): 2,475 @ $19.79 | EDGAR |
Recent 8-K events — Apellis Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-05-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2025-06-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-04-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=APLS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →